... Jun 18
Anti-tumor immune memory and iADC platform are showing results ... Oct 27
Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) platform exclusive license from Sorento... Sep 15
Merck invests in immuno oncology... Sep 10
Antibody-drug conjugate for treating different type of Cancers, starts second phase trial... Aug 25
-Advertisements-